Lace M. Riggs, PhD
Affiliations: | 2012-2016 | Department of Psychology | California State University, San Bernardino |
| 2016-2021 | Program in Neuroscience | University of Maryland School of Medicine, Baltimore, MD, United States | |
| 2021- | Department of Brain and Cognitive Sciences | McGovern Institute for Brain Research at MIT |
Area:
Neuroscience, PhysiologyGoogle:
"Lace Riggs"Mean distance: 17.82 (cluster 31) | S | N | B | C | P |
Parents
Sign in to add mentor| Todd D. Gould | grad student | 2017-2021 | University of Maryland Medical School | |
| (PhD Mentor) | ||||
| Scott M. Thompson | grad student | 2017-2021 | University of Maryland Medical School | |
| (PhD Co-Mentor) | ||||
| Guoping Feng | post-doc | 2021- | McGovern Institute for Brain Research at MIT | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Riggs LM, Pereira EFR, Thompson SM, et al. (2023) cAMP-dependent protein kinase signaling is required for ()-hydroxynorketamine to potentiate hippocampal glutamatergic transmission. Journal of Neurophysiology |
| Riggs LM, Thompson SM, Gould TD. (2022) (2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity. Neuropharmacology. 214: 109153 |
| Hasin N, Riggs LM, Shekhtman T, et al. (2022) Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder. Molecular Psychiatry |
| Highland JN, Morris PJ, Konrath KM, et al. (2022) Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (26)- and (5)-Methyl-(26)-hydroxynorketamines. Acs Chemical Neuroscience. 13: 510-523 |
| Hess EM, Riggs LM, Michaelides M, et al. (2021) Mechanisms of Ketamine and its Metabolites as Antidepressants. Biochemical Pharmacology. 114892 |
| Riggs LM, An X, Pereira EFR, et al. (2021) (R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency. Translational Psychiatry. 11: 583 |
| Highland JN, Zanos P, Riggs LM, et al. (2021) Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications. Pharmacological Reviews. 73: 763-791 |
| Riggs LM, Gould TD. (2021) Ketamine and the Future of Rapid-Acting Antidepressants. Annual Review of Clinical Psychology |
| Wang AQ, Konrath KM, Highland JN, et al. (2020) P199 - HILIC UPLC-MS/MS methods for the assessment of hydroxynorketamines pharmacokinetics in mouse plasma and brain Drug Metabolism and Pharmacokinetics. 35 |
| Riggs LM, Aracava Y, Zanos P, et al. (2019) (2R,6R)-hydroxynorketamine acts through a synapse-specific presynaptic mechanism to rapidly potentiate hippocampal glutamatergic transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |